InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FRE | Ann: Release of DRP documentation | 27/02/23 | 0 | 279 | |||
|
|||||||
FRE | Ann: Half Year Results to 31 December 2022 and Interim Dividend | 07:10 | 0 | 229 | |||
|
|||||||
FRE | Ann: Freightways Limited ("FRE") - Name and Ticker Code Change | 08/02/23 | 0 | 404 | |||
|
|||||||
FRE | Ann: Notification of Name and Ticker Code Change | 08/02/23 | 0 | 219 | |||
|
|||||||
FRE | Ann: Release Date for Half Year Results | 19/01/23 | 0 | 217 | |||
|
|||||||
FRE | Ann: Disclosure Notice - D&O Relevant Interests | 07/12/22 | 0 | 248 | |||
|
|||||||
FRE | Ann: Financial Assistance for the Purchase of Shares | 05/12/22 | 0 | 210 | |||
|
|||||||
FRE | Ann: Shares Issued for Freightways Employee Share Plan | 05/12/22 | 0 | 221 | |||
|
See All Discussions